GeoVax Labs, Inc. — Form 8-K
Filed September 10, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 78/100
What the filing says
GeoVax received a delisting notice from Nasdaq on August 27, 2026, for failing to meet minimum bid price requirements under Rule 5550(a)(2). The company requested a hearing before the Nasdaq Hearings Panel, scheduled for October 13, 2026, which has stayed delisting action pending the hearing outcome. Stock will continue trading on Nasdaq Capital Market (GOVX) through the hearing and any extension period.
Why this rating
Delisting risk is existential threat to $13.7M company; listing integrity critical to funding/partnerships. Hearing provides reprieve but compliance failure remains unresolved.
Price action (we called it negative)
before filing · preread $0.47 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 10, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.